is semaglutide bad for you FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Type 2 diabetes: New Ozempic

Jothydev Kesavadev , MBBS, MD, FRCP, FACP, FACE(USA), Chairman, at Jothydev's Diabetes and Research Center , Trivandrum, India, said, While GLP-1 therapies are driving strong clinical outcomes, there is still a gap when it comes to tracking patient progress in real-world settings

This is avoidable by taking medical records pre-operatively

10.1111/cns.14576 62 JiangX.StockwellB

Mandic-Maravic V, Mitkovic-Voncina M, Pljesa-Ercegovac M, Savic-Radojevic A, Djordjevic M, Ercegovac M, Pekmezovic T, Simic T, Pejovic-Milovancevic M (2021) Glutathione S-transferase polymorphisms and clinical characteristics in autism spectrum disorders